Chronic respiratory diseases involve a heterogenous group of diseases, including,
chronic obstructive pulmonary disease (COPD), asthma, sleep apnea syndrome,
pulmonary hypertension, and many occupational diseases. They affect more than
one billion people worldwide. Their medical, social, and economic impacts are
heavy, especially in developing countries such as Middle East and North Africa
countries, where they represent a public health problem. They are essentially
represented by COPD, asthma, and allergic diseases. Chronic respiratory diseases
are increasing in frequency, morbidity, and mortality. In addition, their
economic and social impact is increasing rapidly in this region. Main risk
factors are represented by tobacco smoking and exposure to biomass fuel. Smoking
prevention and standardized management programs for asthma and COPD are now
available but prompt actions are needed to make them more effective in this
region and thus avoid an adverse impact on national economic development.